Cargando…
Non-alcoholic fatty liver disease, metabolic syndrome, and type 2 diabetes mellitus: where do we stand today?
Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome (MetS), and type 2 diabetes (T2DM) are metabolic disorders that belong to a highly prevalent disease cluster with a significant impact on public health worldwide. MetS is a complex condition characterized by metabolism perturbations that...
Autores principales: | Mitrovic, Bojan, Gluvic, Zoran M., Obradovic, Milan, Radunovic, Maja, Rizzo, Manfredi, Banach, Maciej, Isenovic, Esma R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408022/ https://www.ncbi.nlm.nih.gov/pubmed/37560721 http://dx.doi.org/10.5114/aoms/150639 |
Ejemplares similares
-
Nature and nurture in neuropsychiatric genetics: where do we stand?
por: Dick, Danielle M., et al.
Publicado: (2010) -
Prediction of treatment outcomes in psychiatry—where do we stand ?
por: McMahon, Francis J.
Publicado: (2014) -
The impact of the digital revolution
on human brain and behavior: where
do we
stand?
por: Korte, Martin
Publicado: (2020) -
The Na(+)/K(+)-ATPase: A potential therapeutic target in cardiometabolic diseases
por: Obradovic, Milan, et al.
Publicado: (2023) -
Active surveillance in prostate cancer management: where do we stand now?
por: Dragan, Jędrzej, et al.
Publicado: (2020)